ClinicalTrials.gg
CompletedNCT07675343Updated Oct 28, 2026

Functional Progressive Resistive Training and Cerebral Palsy

An interventional study of functional progressive resistive exercise and designed physical therapy program and designed physical therapy program in Cerebral Palsy, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 28, 2026Now CompletedFirst site in Egypt+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Cerebral Palsy by Cairo University — 28 open to participants now, 34 under way, 1 of them phase 3. Cerebral Palsy · Cairo University.

Enrollment
10th of 94
60 · median 40
Started
2026
with 17 others
No phase
93 of 114
23 open now
Registered
106th of 114
by date

Among the 114 studies in Cerebral Palsy by Cairo University, this one is the 10th largest by enrollment of the 94 interventional ones that give a count, is one of 18 that started in 2026, is one of 93 with no phase, and was the 106th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

28 of the 114 studies in Cerebral Palsy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

23 more — sign in →

By country, each count listing its studies:

All 28 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 10 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Cerebral Palsy by Cairo University, or all of them as a file.
02

Study summary

Functional Progressive Resistive Exercise (FPRE) is a strengthening approach that combines functional movement activities with progressively increased resistance. It involves performing task-oriented exercises, such as sit-to-stand, stair climbing, and walking-related activities, while gradually increasing the load to enhance muscle strength, endurance, and functional performance. FPRE is widely used in rehabilitation programs to improve mobility and the ability to perform activities of daily living in various populations, including children with neurological and musculoskeletal disorders.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • cerebral palsy
  • functional progressive resistive exercise
  • bone mineral density
  • balance
04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A diagnosis of spastic diplegic CP
  2. Degree of spasticity ranges from 1+ and 2, according to modified Ashworth scale (MAS)
  3. The age of the selected children will range from 6 to 10 years old.
  4. Children are levels II and III according to GMFCS

Exclusion criteria

Exclusion Criteria:

1 - Children with visual or auditory problems. 2. Children with severe intellectual disability (IQ less than 65 according to Stanford Binet intelligence scale).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    functional progressive resistive exercise and designed physical therapy program

    Other: functional progressive resistive exercise and designed physical therapy program

  • Experimental
    designed physical therapy program

    Other: designed physical therapy program

Interventions

  • Otherfunctional progressive resistive exercise and designed physical therapy program

    specially designed physical therapy program in addition to functional progressive resistive exercises for 60 min (30 min designed P.T program and other 30 min for brain gym exercises), 3 sessions/ week for 3 successive months. 6 functional progressive resistive exercises will be selected: 1. Sit-to-Stand Exercise 2. Step-Up Exercise 3. Squats 4. Lunges 5. Stair Climbing 6. Loaded Walking

  • Otherdesigned physical therapy program

    conventional physical therapy program including reinforcement of the normal motor development, reflex inhibiting patterns, postural reaction, stretching, strengthening exercises, and gait training was applied to children in the control group

06

What researchers measure

Primary outcomes

  1. Dual-energy X-ray absorptiometry (DXA)

    The most common test for bone mineral density is a Dual-energy X-ray absorptiometry (DXA) scan. It is: Painless and non-invasive Quick (usually 10-20 minutes) Low radiation exposure Most often performed on the hip and lower spine. Bone mineral density (BMD) is a measure of the amount of mineral (mainly calcium and phosphorus) present in a specific volume of bone. It reflects bone strength and is used to assess the risk of fractures and diagnose osteoporosis.

    Time frame: 3month

  2. biodex balance system

    The Biodex Balance System is a computerized device used to assess and improve static and dynamic balance, postural stability, and neuromuscular control. It consists of a movable platform that can be adjusted to different levels of stability, allowing clinicians and researchers to evaluate an individual's ability to maintain balance under varying conditions.

    Time frame: 3 month

07

Study locations

1 site
  • Cairo University
    Cairo, Giza Governorate, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Sep 2026, 2 months.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 2 months is below that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: primary completion Aug 2026 → Sep 2026 and completion Nov 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2026
First posted
Jun 30, 2026
StartActual
Jul 1, 2026
Primary completionActual
Sep 22, 2026was Aug 2026
CompletionActual
Oct 9, 2026was Nov 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 28, 2026
Sites
1 site added — first site in Egypt
Show site
  • Cairo University · Cairo, Egypt
Oct 28, 2026
Primary completion
Aug 11, 2026→Sep 22, 2026 (actual)
Oct 28, 2026
Study completion
Nov 9, 2026→Oct 9, 2026 (actual)
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Not yet recruiting→Completed
    1 site added — first site in Egypt
    Show site
    • Cairo University · Cairo, Egypt
    Primary completion Aug 11, 2026→Sep 22, 2026 (now actual)
    Study completion Nov 9, 2026→Oct 9, 2026 (now actual)
    + 3 other changes: identifiers, verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07675343
Lead sponsor
Cairo University
Responsible party
Alaa Fahmy Hassan Al Nemr (assistant professor at faculty of physical therapy, cairo university, Cairo University) — Principal investigator
First posted
Jun 30, 2026
Start date
Jul 1, 2026
Primary completion
Sep 22, 2026
Completion
Oct 9, 2026
Last update
Oct 28, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion